Cargando…
High expression of fibroblast activation protein (FAP) predicts poor outcome in high-grade serous ovarian cancer
BACKGROUND: High-grade serous ovarian cancer (HGSOC) is a fatal form of ovarian cancer. Previous studies indicated some potential biomarkers for clinical evaluation of HGSOC prognosis. However, there is a lack of systematic analysis of different expression genes (DEGs) to screen and detect significa...
Autores principales: | Li, Min, Cheng, Xue, Rong, Rong, Gao, Yan, Tang, Xiuwu, Chen, Youguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7590670/ https://www.ncbi.nlm.nih.gov/pubmed/33109151 http://dx.doi.org/10.1186/s12885-020-07541-6 |
Ejemplares similares
-
High expression of Tie-2 predicts poor prognosis in primary high grade serous ovarian cancer
por: Sopo, Minna, et al.
Publicado: (2020) -
High expression of ENPP1 in high-grade serous ovarian carcinoma predicts poor prognosis and as a molecular therapy target
por: Wang, Hanzhi, et al.
Publicado: (2021) -
Lipid Droplet Accumulation Independently Predicts Poor Clinical Prognosis in High-Grade Serous Ovarian Carcinoma
por: Iwahashi, Naoyuki, et al.
Publicado: (2021) -
Abnormal methylation characteristics predict chemoresistance and poor prognosis in advanced high-grade serous ovarian cancer
por: Feng, Li-yuan, et al.
Publicado: (2021) -
Low Expression of Circular RNA hsa_circ_0078607 Predicts Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Zhang, Nan, et al.
Publicado: (2021)